Implementation of flu vaccination in community pharmacies: Understanding the barriers and enablers

Summary

Improving influenza vaccination coverage has been, and still remains a challenge internationally. There are now many examples where countries have pursued a pharmacist-led influenza vaccination service in order to enhance vaccination coverage of at-risk populations. England, Portugal and the United States are successful examples where their experience implementing this service can now be explored retrospectively and learnt from. This review aims to provide evidence to help overcome barriers to commissioning and implementation of such services in countries new to the experience. Implementation is influenced by differing regulatory frameworks underpinning the provision of pharmacist-led influenza vaccination, methods of remuneration, training, and operating procedures. Practical aspects such as the facilities required, how patient records are maintained and how patients and other healthcare professionals are engaged also have an impact. These examples illustrate how community pharmacists can be trained to deliver influenza vaccinations safely, and coupled with their accessibility and convenience, can provide a complementary service to that already provided by family doctors and nurses to deliver influenza vaccinations for the benefit of patients.

Résumé

Améliorer la protection contre la grippe saisonnière reste un défi international. Dans le but d’accroître la couverture vaccinale de leur population à risque, plusieurs pays ont déployé avec succès un service de vaccination antigrippale par le pharmacien. Les expériences concluantes de l’Angleterre, du Portugal et des États-Unis notamment, permettent d’étudier des modèles de déploiement de ce nouveau service en officine. Cet article vise à éclairer, de façon pratique, la mise en place de la vaccination par les pharmaciens d’officine et sa prise en charge par les systèmes de santé. Le déploiement de ce service est notamment déterminé par la réglementation, la formation, la rémunération, les procédures d’administration. Des aspects pratiques comme les installations nécessaires dans les pharmacies, la gestion des dossiers patients, la coordination avec les autres professionnels de santé ainsi que la communication auprès des patients ont aussi un impact fort. Ces exemples montrent comment les pharmaciens d’officine peuvent être formés pour administrer des vaccins contre la grippe en toute sécurité, et comment grâce à leur accessibilité et à leur proximité, ils peuvent fournir un service complémentaire à celui des médecins et des infirmières pour le bénéfice du patient et de la santé publique.

Introduction

Improving seasonal influenza (flu) vaccination coverage in at-risk populations is important because of the increased risk that this population has from the effects of flu infection. Flu infection of those in at-risk groups is associated with between a five- (diabetes) and 50-fold (immunosuppressed) increase in mortality rate, compared to non-at-risk individuals. In recognition of this, the European Union (EU) Council recommended a target of 75% vaccination coverage amongst the elderly (and to extend if possible to cover those with certain chronic conditions) which was adopted by the EU in 2009, with the aim of member countries meeting this target by the 2014/15 season. The majority of countries are currently struggling to meet this target, with only two of the EU member states achieving this in the elderly population in the 2012/13 season [parts of the United Kingdom (UK) and The Netherlands] [1]. This calls into question what other countries are doing to increase their vaccination rates, including the benefits of pharmacist-led flu vaccination services in community pharmacy [2] according to increasing international experiences [3].

Whilst legislation and healthcare systems across countries differ, there are still lessons that can be learnt about facilitators, enablers and barriers to change. This article aims to explore examples of these in other countries that have undergone this process. Countries have been chosen which have established community pharmacy-provided vaccination services and where information has been published on factors surrounding implementation and delivery. England, Portugal and the United States (US) will be the primary examples. Table 1 provides an overview of the number of pharmacies providing flu vaccinations in these Countries.

Vaccinations have traditionally been delivered by family doctors; however, since the 1990s community pharmacists have been increasingly utilised to provide additional vaccination services in countries such as Canada, Portugal, the UK and US [4]; and more recently in New Zealand, Switzerland and Australia [5], [6], [7], [8]. Community pharmacies are ideally placed to provide additional capacity for flu vaccination services employing highly trained clinical professionals in an accessible environment [9]. They are often open longer than conventional working hours, patients do not require appointments (although can make them if preferred), and they have wide coverage including more deprived localities and in medically underserved locations [10], [11]. Research shows that patients from more deprived backgrounds, who are often hard to target, access pharmacy for flu vaccination [10], [12]. Community pharmacy has attracted those patients who have not been previously vaccinated by traditional providers (e.g. family doctors); a study in England found that not only were vaccination rates of the elderly (> 65 years of age) and at-risk populations improved with the introduction of flu vaccination through community pharmacy, but also in those who had been eligible previously for vaccination but had never received it [13]. In Canada, a pharmacy-based flu vaccination service was evaluated and found that 28% of those vaccinated would not have been without the service, and 21% of these were at-risk patients [14]. In the first season of instigation of the Portuguese campaign, 13% of those vaccinated in pharmacy had never had a flu vaccination before. These studies demonstrate that community pharmacy can provide a complementary service to that of medical providers, and thus support other healthcare professionals to improve overall vaccination rates and reach the EU 75% target.

Flu vaccination rates of the elderly in France have remained fairly static in the last decade, reaching 66% in 2010 [15] and dropping back down to approximately 53% in the 2012/13 season [1], providing evidence that France has not yet been able to reach the EU targets of vaccination coverage, a trend also mirrored in other European countries [16]. Evidence from other Countries demonstrates that community pharmacy could provide a solution to help reach these targets [10], [13], [14], [17]; however, it is also important to understand and appreciate the barriers that are associated with expanding the role of pharmacists [18], [19]. Each country has had to develop a model to fit their different healthcare systems and populations, and often the pace of change has been slow, but this allows us to learn from their experiences. The methods of implementation and management of flu vaccination in community pharmacy vary widely, from large nationally commissioned, rapidly implemented programmes, to slow-growing, locally variable and privately-provided services. Nevertheless, there are a diversity of examples of methods to provide the seasonal flu vaccine through community pharmacy that a new healthcare provider need not start from first principles, but learn from the successes and barriers faced by others. The key areas that will be discussed are regulation, legal supply, delivery, training, engagement, payment and record keeping (Table 2).